IONIS PHARMACEUT reported $158.25M in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Agios Pharmaceuticals AGIO:US USD 3M 2.15M
Alnylam Pharmaceuticals ALNY:US USD 223.19M 39.18M
Astellas Pharma 4503:JP JPY 317.61B 24.69B
Biocryst Pharmaceuticals BCRX:US USD 72.21M 6.93M
Biomarin Pharmaceutical BMRN:US USD 389.06M 21.62M
Bluebird Bio BLUE:US USD 71K 297K
Esperion Therapeutics ESPR:US USD 12.47M 2.81M
Exelixis EXEL:US USD 396.43M 9.51M
Halozyme Therapeutics HALO:US USD 161.66M 43.24M
Intercept Pharmaceuticals ICPT:US USD 77.16M 5.72M
Moderna Inc MRNA:US USD 2.26B 1.1B
Nektar Therapeutics NKTR:US USD 18.65M 2.18M
Neurocrine Biosciences NBIX:US USD 381.8M 8.4M
Novartis NOVN:VX USD 9.18B 151M
Pfizer PFE:US USD 16.55B 2.52B
Ptc Therapeutics PTCT:US USD 203.12M 47.23M
Regeneron Pharmaceuticals REGN:US USD 2.62B 58.3M
Sarepta Therapeutics SRPT:US USD 190.32M 5.38M
Ultragenyx Pharmaceutical RARE:US USD 82.07M 999K
Vertex Pharmaceuticals VRTX:US USD 2.04B 110.5M